Aclaris Therapeutics Inc (ACRS)
1.185
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
1.185
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Price to Book Value: 0.5972 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 0.5972 |
| May 16, 2024 | 0.5921 |
| May 15, 2024 | 0.5921 |
| May 14, 2024 | 0.5921 |
| May 13, 2024 | 0.5921 |
| May 10, 2024 | 0.5871 |
| May 09, 2024 | 0.6147 |
| May 08, 2024 | 0.6122 |
| May 07, 2024 | 0.6724 |
| May 06, 2024 | 0.6574 |
| May 03, 2024 | 0.6825 |
| May 02, 2024 | 0.6574 |
| May 01, 2024 | 0.6323 |
| April 30, 2024 | 0.6072 |
| April 29, 2024 | 0.6122 |
| April 26, 2024 | 0.6022 |
| April 25, 2024 | 0.5972 |
| April 24, 2024 | 0.5871 |
| April 23, 2024 | 0.6122 |
| April 22, 2024 | 0.6122 |
| April 19, 2024 | 0.6223 |
| April 18, 2024 | 0.6172 |
| April 17, 2024 | 0.6172 |
| April 16, 2024 | 0.6122 |
| April 15, 2024 | 0.6071 |
| Date | Value |
|---|---|
| April 12, 2024 | 0.6071 |
| April 11, 2024 | 0.6121 |
| April 10, 2024 | 0.582 |
| April 09, 2024 | 0.597 |
| April 08, 2024 | 0.597 |
| April 05, 2024 | 0.597 |
| April 04, 2024 | 0.6171 |
| April 03, 2024 | 0.6271 |
| April 02, 2024 | 0.6121 |
| April 01, 2024 | 0.6321 |
| March 31, 2024 | |
| March 28, 2024 | 0.5595 |
| March 27, 2024 | 0.5686 |
| March 26, 2024 | 0.5325 |
| March 25, 2024 | 0.5234 |
| March 22, 2024 | 0.5189 |
| March 21, 2024 | 0.5415 |
| March 20, 2024 | 0.537 |
| March 19, 2024 | 0.5189 |
| March 18, 2024 | 0.5189 |
| March 15, 2024 | 0.5279 |
| March 14, 2024 | 0.5189 |
| March 13, 2024 | 0.564 |
| March 12, 2024 | 0.5505 |
| March 11, 2024 | 0.5821 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.237
Minimum
Aug 14 2019
38.15
Maximum
Mar 22 2021
4.338
Average
3.573
Median
Dec 06 2021
Price to Book Value Benchmarks
| Aldeyra Therapeutics Inc | 2.069 |
| CEL-SCI Corp | 4.808 |
| AIM ImmunoTech Inc | 2.107 |
| IGC Pharma Inc | 3.942 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 2.709 |
| Price | 1.185 |
| Earnings Yield | -91.60% |
| Market Cap | 84.81M |